Biogen’s stock gets a big boost from 2 upgrades a week before earnings

Biogen’s stock rallies to 2-year high after two analysts raise their ratings to buy and their price targets to at least $400.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.